As of 2025-07-22, the Fair Value of Ocuphire Pharma Inc (OCUP) is -2.23 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.17 USD, the upside of Ocuphire Pharma Inc is -290.95%.
With the market price of 1.17 USD and our fair value calculation, Ocuphire Pharma Inc (OCUP) is not a good investment. Investing in OCUP stocks now will result in a potential loss of 290.95%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -8.64 | -24.62 | -56.69 | 17.89 | -9.99 | -16.41 |
| YoY growth | 39.87% | -184.95% | -130.26% | 131.56% | -155.82% | -59.92% |
| Market Cap (mil) | 36.94 |
| P/E | |
| Forward P/E |
| EPS | -0.45 |
| Avg earnings growth rate | -59.92% |
| TTM earnings | -14.11 |